Early dysregulation of GSK3β impairs mitochondrial activity in Fragile X Syndrome.

导出 LinkOut

翻译打印收藏纠错

第一作者： Giulia,Cencelli

第一单位： Department of Biomedicine and Prevention, University of Rome Tor Vergata, 00133 Rome, Italy.

作者： Giulia,Cencelli ^[1] ; Giorgia,Pedini ^[1] ; Carlotta,Ricci ^[1] ; Eleonora,Rosina ^[1] ; Giorgia,Cecchetti ^[1] ; Antonietta,Gentile ^[1] ; Giuseppe,Aiello ^[2] ; Laura,Pacini ^[3] ; Beatrice,Garrone ^[4] ; Rosella,Ombrato ^[4] ; Isabella,Coletta ^[4] ; Federica,Prati ^[4] ; Claudio,Milanese ^[4] ; Claudia,Bagni ^[5]

作者单位： Department of Biomedicine and Prevention, University of Rome Tor Vergata, 00133 Rome, Italy. ^[1] Department of Fundamental Neurosciences, University of Lausanne, 1005 Lausanne, Switzerland. ^[2] Department of Biomedicine and Prevention, University of Rome Tor Vergata, 00133 Rome, Italy; Faculty of Medicine, UniCamillus, Saint Camillus International University of Health and Medical Sciences, 00131 Rome, Italy. ^[3] Angelini Pharma S.p.A., 00181 Rome, Italy. ^[4] Department of Biomedicine and Prevention, University of Rome Tor Vergata, 00133 Rome, Italy; Department of Fundamental Neurosciences, University of Lausanne, 1005 Lausanne, Switzerland. Electronic address: claudia.bagni@unil.ch. ^[5]

关键词 Autism Coactivator (PGC) 1-alpha GSK3β-inhibitor Intellectual disabilities Peroxisome Proliferator-Activated Receptor Gamma